Published in Int J Pharm on June 04, 2002
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood (2006) 2.13
Drug transport to brain with targeted nanoparticles. NeuroRx (2005) 1.37
Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech (2010) 0.85
Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment. Surgery (2008) 0.84
The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomedicine (2012) 0.81
Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. J Mater Sci Mater Med (2010) 0.80
Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability. Adv Pharm Bull (2012) 0.79
Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug Des Devel Ther (2015) 0.79
Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomedicine (2012) 0.78
Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model. Dig Dis Sci (2013) 0.77
Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation. Drug Des Devel Ther (2015) 0.76
Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics. Cancer Nanotechnol (2013) 0.75
Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma. Drug Des Devel Ther (2015) 0.75
Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo. Sci Technol Adv Mater (2014) 0.75
Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm (2000) 2.58
Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm (2006) 1.46
Clamped homogenous electric fields (CHEF) gel-electrophoresis of DNA restriction fragments for comparing genomic variations among strains of yersinia enterocolitica and Yersinia spp. Zentralbl Bakteriol (1994) 1.20
Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm (2008) 1.18
The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake. Anticancer Res (1995) 1.18
Application of experimental design methodology in development and optimization of drug release method. Int J Pharm (2005) 1.16
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm (2009) 1.03
Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry in vivo. J Control Release (2001) 1.01
Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods. J Microencapsul (1991) 0.95
Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm (2003) 0.95
Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release (1999) 0.94
The effect of hypoxia and low pH on the cytotoxicity of chlorambucil. Int J Radiat Oncol Biol Phys (1992) 0.93
Influence of different anesthetics on skin oxygenation studied by electron paramagnetic resonance in vivo. Skin Pharmacol Physiol (2006) 0.90
Comparative rheological investigation of crude gastric mucin and natural gastric mucus. Biomaterials (1997) 0.89
An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int J Pharm (2006) 0.88
Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int J Pharm (2010) 0.87
Preformulation investigation of the novel proton pump inhibitor lansoprazole. Drug Dev Ind Pharm (2000) 0.85
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam. Int J Pharm (2009) 0.83
Possible role of jasmonic acid in the regulation of floral induction, evocation and floral differentiation in Lemna minor L. Plant Physiol Biochem (2006) 0.83
The topography of electrospun nanofibers and its impact on the growth and mobility of keratinocytes. Eur J Pharm Biopharm (2012) 0.82
Influence of liposome bilayer fluidity on the transport of encapsulated substance into the skin as evaluated by EPR. Pharm Res (1998) 0.80
Physiological barriers to the oral delivery of curcumin. Pharmazie (2012) 0.79
Polarised transport of monocarboxylic acid type drugs across rat jejunum in vitro: the effect of mucolysis and ATP-depletion. Int J Pharm (2003) 0.78
Similarity of solid state structures of R- and S-isomers of clopidogrel hydrogensulphate salt. Pharmazie (2010) 0.78
Transport of liposome-entrapped substances into skin as measured by electron paramagnetic resonance oximetry in vivo. Methods Enzymol (2004) 0.78
Influence of spin probe structure on its distribution in SLN dispersions. Int J Pharm (2000) 0.77
Genomic analyses of Salmonella enteritidis phage type 4 strains from Austria and phage type 8 strains from the United States. Zentralbl Bakteriol (1997) 0.77
Optimization of melt pelletization in a high shear mixer. Int J Pharm (2009) 0.75
[Evaluation of the effects of 2 oral anaesthetic formulations on the oral mucosa using a questionnaire]. Zobozdrav Vestn (1982) 0.75
[Bioadhesive polymeric films for the application onto the oral mucosa]. Zobozdrav Vestn (1988) 0.75
Efficiency and usability of silicone surfactants in emulsions. Int J Cosmet Sci (1990) 0.75
Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties. Pharmazie (2016) 0.75
Effect of renal transplantation on lecithin cholesterol acetyltransferase (LCAT) activity and plasma lipids. Physiol Bohemoslov (1983) 0.75
Oxidation of lovastatin in the solid state and its stabilization with natural antioxidants. Pharmazie (2001) 0.75
Comparative permeability of some acyclovir derivatives through native mucus and crude mucin dispersions. Drug Dev Ind Pharm (2001) 0.75
[Effect of cortisol on the composition of cerebrospinal fluid and plasma in the chick embryo (author's transl)]. Sb Lek (1978) 0.75
The effect of cores and coating dispersion composition on the mechanical and adhesion properties of hydroxypropyl methylcellulose films. Pharmazie (2014) 0.75
Development and optimization of the drug release determination of iron from iron prolonged release tablets. Pharmazie (2003) 0.75
[Usefulness of hydrogel-based formulations in the treatment and protection of wounds of the oral mucosa]. Zobozdrav Vestn (1982) 0.75
Microbiological quality assurance of purified water by ozonization of storage and distribution system. Drug Dev Ind Pharm (2006) 0.75
[Guidelines for updating magistral recipes used in dentistry]. Zobozdrav Vestn (1986) 0.75
[Stimulation of anesthetic release from hydrogels]. Zobozdrav Vestn (1983) 0.75
Physical characterization of pantoprazole sodium hydrates. Int J Pharm (2004) 0.75
Influence of metal cations on the solubility of fluoroquinolones. Pharmazie (2007) 0.75
Viscosity prediction of lipophilic semisolid emulsion systems by neural network modelling. Int J Pharm (2000) 0.75
The use of a combination of different MR methods to study swelling of hydrophilic xanthan matrix tablets at different pHs. Prilozi (2012) 0.75
[Drug liberation from dermatica (author's transl)]. Pharmazie (1982) 0.75
[The influence on some physicochemical parameters on drug release from PMMA salt hydrogels]. Pharmazie (1984) 0.75
Design of a drug delivery system with bimodal pH dependent release of a poorly soluble drug. Pharmazie (2011) 0.75
Physicochemical characterization of protein-loaded pectin-chitosan nanoparticles prepared by polyelectrolyte complexation. Pharmazie (2010) 0.75
Interactions of biopolymers carrageenans with cationic drug doxazosin mesylate characterized by means of differential scanning calorimetry. Pharmazie (2010) 0.75